The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

BACKGROUND: Great success has been made in the targeting therapy of advanced non-small cell lung cancer (NSCLC). Nowadays, next generation sequencing (NGS) is acquirable and affordable in developed area of China. Using this feasible and accurate method of detecting therapeutic genes would help to se...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Res Int
Hlavní autoři: Zhang, Yan, Shen, Wen-Xiang, Zhou, Li-Na, Tang, Min, Tan, Yue, Feng, Chun-Xia, Li, Ping, Wang, Li-Qiang, Chen, Min-Bin
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7003276/
https://ncbi.nlm.nih.gov/pubmed/32047821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/9387167
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky